Aurorium, a specialty ingredients manufacturer, has launched Haelium Pharmaceutical Solutions.
This novel brand extends Europium’s offering in the pharmaceutical ingredients sector, allowing the company to expand in the space.
Inspired by the old English word ‘hælan’, which means ‘to cure’, the Haelium brand embodies a distinctive approach to pharmaceuticals, according to the company.
It will provide solutions such as high-purity buffers, reagents, solvents, extended-release coatings and immunostimulants for a range of therapeutic areas, as well as peptide and oligonucleotide, large molecule biologics, vaccine and oral solid dosage production capabilities.
Vice President, Specialty Solutions, Dr Steve Tattum, added: “Investing in the pharmaceutical space will allow us to improve patient outcomes. With these strategic investments, we aim to support research and development that will shape the future of medicine and advance global health. From the inception of novel ideas to product launches, our priority is to fuel our customer’s success by partnering to solve their challenges.”
